The change in sales mix relates to the increasing portion of our revenues from our molecular diagnostic items which we sell to hospitals directly. These hospitals normally pay out us in 6 to 12 a few months and the bigger the hospital, the longer the payment cycle. However, we consider the chance of bad personal debt from these hospitals to end up being very low considering that they are tier 1 hospitals, possess a strong financial position and are government-owned.Related StoriesConfocal microscope designed specifically for scientists released by Caliber IDNew results reveal association between colorectal tumor and melanoma drug treatmentRapid, award earning diagnostic checks to be offered at MEDICAThis system relies on functionalized electrodes binding to olfactory receptors with the capacity of sending tiny electric signals, which are detected and amplified subsequently. The problem is to develop totally new arrays of olfactory receptors to procedure different smells for different diseases. Its applications are manifold. For instance, prostate cancer could be detected through the evaluation of urine samples. The project researchers combined artificial cleverness with sensing technology to design noses that display better performance than available olfactory technology.